Development phase / fragment / area / management path / Approximate approximate date / Ongoing clinical trials

Dublin, December 23, 2020 (GLOBE NEWSWIRE) – Added Report “Balloon Catheters PTA – Medical Equipment Pipe Assessment, 2020” ResearchAndMarkets.com’s offering.

“PTA Balloon Catheters Pipeline Evaluation, 2020” provides complete information on PTA Balloon Catheters pipeline results with a comparative analysis of the results at various stages of development and information on the ongoing clinical trials. forward.

The PTA Balloon Catheters division includes General Balloon Catheters and Peripheral PTA DEB Catheters. DCB Peripheral Catheter DCB is a drug-coated transluminal angioplasty (PTA) balloon aimed at preventing restenosis, or restenosis of the peripheral arteries. Conventional balloon catheters are used to open the arteries that are blocked by plaque buildup (atherosclerosis).

Scope

  • Extensive coverage of the PTA Balloon Catheters under development
  • The report reviews details of key pipeline outputs that include, product description, licensing and collaboration details and other development activities.
  • The report reviews the key players involved in the development of PTA Balloon Catheters and lists their piping projects.
  • Broadcast of pipe materials based on various stages of development from early development to agreed / achieved stage
  • The report provides key clinical trial data of follow-up trials specific to pipeline results.
  • Recent developments in the sector / industry

Reasons to buy

  • Combine a wealth of competitive intelligence, analysis and insights to develop R&D strategies
  • Identify emerging players with a potentially strong product portfolio and create effective strategies to gain competitive advantage
  • Identify and understand important and diverse types of PTA balloon receivers that are being developed
  • Develop market entry and market expansion strategies
  • Design unions and gains effectively by identifying key players with the most promising pipeline
  • Analysis of development stage, product and product launch date

Key topics covered:

1 Contents

2 Introduction
2.1 Review of PTA Balloon Catheters

3 Goods in Development
3.1 PTA-Pipe-Output Balloon Catheters by Development Stage
3.2 Balloon Catheters PTA-Pipe Results by Segment
3.3 Balloon Catheters PTA-Pipe Results by Land
3.4 PTA-Pipe-Output Balloon Catheters by Regulatory Route
3.5 PTA balloon catheters output according to approximate agreed date
3.6 Balloon Catheters PTA – Ongoing Clinical Trials

4 PTA Balloon Catheters Products Under Development by Companies
4.1 PTA-Balloon Catheters Companies-Pipe Products by Development Stage
4.2 PTA Balloon Catheters-Pipe Fittings by Development Stage

5 PTA Balloon Catheters Companies and Product Review

6 Balloon Catheters PTA – Recent Developments

7 Appendix

Companies mentioned

  • Andramed GmbH
  • AnGes Inc.
  • AngioCure, Inc.
  • Boston Scientific Corp.
  • Cagent Vascular LLC
  • Cardiovascular Systems Inc.
  • Concept Medical Inc.
  • Contego Medical LLC
  • Endocor GmbH
  • eucatech AG
  • Genesis MedTech International Pvt Ltd.
  • SA Hexacath
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Lutonix Inc.
  • MA Med Alliance SA
  • Medtronic Plc
  • Micell Technologies Inc.
  • MicroPort Endovascular (Shanghai) Co., Ltd.
  • NuVascular Technologies Inc.
  • BioMed Orchestra Inc.
  • QT Vascular Limited
  • QualiMed Innovative Medizinprodukte GmbH
  • SiL Vascular Limited
  • Corp Spectranetics
  • SurModics Inc.
  • Tailoring Medical Instruments Inc.
  • Transit Scientific LLC
  • TransMed7 LLC
  • Vascular Nanotransfer Technologies
  • Zhejiang Zylox Medical Appliance Limited

For more information about this report, visit https://www.researchandmarkets.com/r/8h5ajg

Research and Markets also offers Custom Search services providing targeted, complete and unique search.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

.Source